AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ICL Group Ltd.

Foreign Filer Report Mar 13, 2019

Preview not available for this file type.

Download Source File

6-K 1 dp103606_6k.htm FORM 6-K

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of March, 2019

Commission File Number: 001-13742

ISRAEL CHEMICALS LTD.

(Exact name of registrant as specified in its charter)

Israel Chemicals Ltd.

Millennium Tower

23 Aranha Street

P.O. Box 20245

Tel Aviv, 61202 Israel

(972-3) 684-4400

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F X Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes No X

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes No X

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

ISRAEL CHEMICALS LTD.

INCORPORATION BY REFERENCE

This report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form S-8 (Registration Number: 333-205518) of Israel Chemicals Ltd. and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. In addition, this report on Form 6-K shall be deemed to be incorporated by reference into the Israeli Shelf Prospectus of Israel Chemicals Ltd. filed with the Israel Securities Authority and dated March 4, 2019 (Filing Number: 2019-02-018507) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

Field: Page; Sequence: 2

Field: /Page

ISRAEL CHEMICALS LTD.

  1. Replacement of ICL’s Chairman of the Board

Field: Page; Sequence: 3

Field: /Page

Item 1

Replacement of ICL’s Chairman of the Board

The Company hereby reports Mr. Johanan Locker's end of tenure as a board member and as the Executive Chairman of ICL's Board of Directors, following a successful term in office.

ICL's Board of Directors thanked Mr. Locker for his very important contribution in leading ICL's new strategy, adhering the strategy to the challenges of the coming years and to the positioning of ICL.

Mr. Locker has outlined the path for ICL to continue to be a leading and an excellent industrial company in Israel and worldwide, being an anchor for employment in the Negev and for Israeli exports.

ICL's Board of Directors has chosen Mr. Yoav Doppelt, the new CEO of Israel Corporation Ltd., a board member of ICL's Board of Directors, to serve as ICL's Executive Chairman of the Board.

The starting date of Mr. Doppelt's tenure as ICL's Executive Chairman of the Board is expected to be during the second quarter of 2019.

Field: Page; Sequence: 4

Field: /Page

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

/s/ Kobi Altman
Name: Kobi Altman
Title: Chief Financial Officer
/s/ Aya Landman
Name: Aya Landman
Title: Global Company Secretary

Date: March 13, 2019

Field: Page; Sequence: 5; Options: Last

Field: /Page

Talk to a Data Expert

Have a question? We'll get back to you promptly.